Amendment to Employment Agreement between Interleukin Genetics, Inc. and Kenneth S. Kornman
Interleukin Genetics, Inc. and Kenneth S. Kornman have agreed to extend Kornman's employment agreement until March 31, 2003. The amendment also changes the terms for termination without cause, specifying that if Kornman is terminated without cause or if his employment is not extended beyond March 31, 2004, he will receive his base salary and health insurance benefits for one year after termination. All other terms of the original agreement remain unchanged.
EXHIBIT 10.37
AMENDMENT TO EMPLOYMENT AGREEMENT
RECITAL
Interleukin Genetics, Inc., employer, and Kenneth S. Kornman, employee, do mutually desire to amend an existing employment agreement, dated December 1999 and incorporated herein by reference, as follows:
AMENDMENT TO THE EMPLOYMENT AGREEMENT
The employer and the employee agree that the Term of the current Employment Agreement between the two parties shall be extended until March 31, 2003 without alteration, except that the second sentence in Section 6(e) (Termination Without Cause) shall be deleted and the following language shall be substituted therefor:
“If Employee is so terminated by Employer pursuant to this Section 6(e) during the Term, or if the Term of the current employment is not further extended until at least March 31, 2004, Employer shall (i) pay to Employee the Base Salary ($276,250 per year), and (ii) provide the same health insurance benefits to which Employee was entitled hereunder, both for a period of one year commencing with the date of termination.”
| EMPLOYER |
| EMPLOYEE |
| ||||||
|
|
|
|
| ||||||
|
|
|
|
| ||||||
| By | /s/ Philip R. Reilly |
| By | /s/ Kenneth S. Kornman |
| ||||
|
| Philip R. Reilly, CEO |
|
| Kenneth S. Kornman |
| ||||
|
| Interleukin Genetics, Inc. |
|
|
| |||||
|
|
|
|
|
| |||||
|
|
|
|
|
| |||||
| Date: | 12/06/02 |
|
| Date: | 12/06/02 |
|
| ||
